OnKure Therapeutics, Inc. (ticker: OKUR) is an NASDAQ-listed pharma company. DredgeCap's structured extraction of OKUR's SEC filings surfaces 1 active risk signal, including 1 auditor-change signal. OKUR reported $0 in revenue and -$15.16M for the period ending 2024-12-31, with operating cash flow of -$12.94M. Cash and equivalents stood at $192.11M (up 98.7% year-over-year). Total assets of $198.69M exceed total liabilities of $14.34M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.
OKUR Legal Proceedings
DredgeCap has not located any disclosed legal proceedings for OnKure Therapeutics, Inc. (OKUR) in the SEC filings currently cached or in the federal-court records searched. 0 periodic filings reviewed, 0 with specific disclosure content. The absence of records here does not certify that the company is free of litigation — coverage reflects only what DredgeCap has cached.